As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

As President Donald Trump tries to reduce overhead costs in federal grants, research institutions are trying to explain it's ...

The Crimson spoke to a range of commercial realtors, startup founders, and a commercial lab space owner to understand how the immense draw of Kendall Square has forced the myriad startup companies ...

The NIH has had its missteps — opaque grant review processes, funding imbalances and institutional inertia. But this is not reform.

A new policy for how the National Institutes of Health will reimburse overhead costs associated with research grants could ...

Texas now has 16 schools — including medical centers — reaching the elite R1 Carnegie classification under a revamped system.

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

It costs money to maintain the various facilities, utilities and personnel that allow scientists to conduct research in the ...

The National Institutes of Health would slash funding for medical research doesn't make even cynical political sense. It's a ...

Tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.